Soft Tissue Repair Industry

The global soft tissue repair market size was valued at USD 14.65 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2030.

The market for soft tissue repair is expanding due to the increasing occurrence of sports injuries and the growing elderly population who are more susceptible to such injuries. Additionally, advancements in minimally invasive surgical techniques and innovative products such as bioengineered scaffolds and regenerative medicine improve treatment outcomes and stimulate market growth. The rise in obesity rates, which is linked to a higher incidence of soft tissue injuries, and the increasing demand for cosmetic surgeries are also driving market growth. Moreover, the emphasis on enhancing patient outcomes and increased healthcare spending is leading to greater adoption of advanced soft tissue repair solution

Gather more insights about the market drivers, restrains and growth of the Global Soft Tissue Repair market

Increasing research and development activities, especially by established companies, are driving the market's growth. The rise in product launches and the high adoption of advanced technology are expected to propel market growth further. Additionally, well-structured healthcare systems in regions such as North America facilitate the early adoption of new technology and products.

The increasing popularity of minimally invasive surgical methods, which offer shorter recovery times and less postoperative pain, is accelerating the market growth. The growing preference for minimally invasive surgeries is driven by advancements in medical technology, including enhanced imaging systems and specialized surgical instruments, which enable surgeons to perform complex repairs with greater accuracy. This trend is expected to continue driving the growth of the soft tissue repair market, as more patients and healthcare providers recognize the benefits of these innovative approaches.

Soft Tissue Repair Market Report Segmentation

• Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Tissue Matrix
    • Synthetic Mesh
    • Biological Mesh
    • Allograft
    • Xenograft
  • Tissue Fixation Products
    • Suture Anchors
    • Interference Screws
    • Other Fixation Devices
  • Laparoscopic Instruments
• Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Hernia Repair
  • Cardiovascular
  • Skin Repair
  • Orthopedic
  • Dental
  • Breast Reconstruction Repair
  • Vaginal Sling Procedures
  • Other applications
• End Use Insights (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Outpatient Facilities
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • Italy
    • France
    • Spain
    • Norway
    • Sweden
    • Denmark
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Key Companies & Market Share Insights

Some key companies in the soft tissue repair market include Stryker Corporation; Smith & Nephew Plc.; Becton, Dickinson and Company; Arthrex, Inc.; Medtronic Plc.; Johnson & Johnson and others. To position themselves more competitively in the market, key players actively engage in various partnerships, mergers, and acquisitions. This strategic approach aims to expand their device range and extend their presence into new business territories. Furthermore, these companies employ tactics such as product differentiation and bundling strategies to secure a larger portion of the market share.

Key Soft Tissue Repair Companies:

The following are the leading companies in the soft tissue repair market. These companies collectively hold the largest market share and dictate industry trends.

• Becton, Dickinson and Company
• Stryker Corporation
• Smith & Nephew Plc.
• Arthrex, Inc.
• Medtronic Plc.
• Johnson & Johnson
• Zimmer Biomet
• Baxter International, Inc.
• Integra LifeSciences
• Artivion, Inc. (CryoLife, Inc.)
• ACell Inc.
• Tissue Regenix Group Plc;

Recent Developments

• In June 2024, Axogen announced the launch of resorbable soft tissue allograft, Avive+ soft tissue matrix. It offers protection and heals peripheral nerve post traumatic injury.

Order a free sample PDF of the Soft Tissue Repair Market Intelligence Study, published by Grand View Research.